Diethylcathinone
| Diethylcathinone
| |
| Systematic (IUPAC) name | |
| 2-diethylamino-1-phenyl-propan-1-one | |
| Identifiers | |
| CAS number | |
| ATC code | A08 |
| PubChem | |
| Chemical data | |
| Formula | C13H19NO |
| Mol. mass | 241.76 |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
B |
| Legal status | |
| Routes | ? |
|
WikiDoc Resources for Diethylcathinone | |
|
Articles | |
|---|---|
|
Most recent articles on Diethylcathinone Most cited articles on Diethylcathinone | |
|
Media | |
|
Powerpoint slides on Diethylcathinone | |
|
Evidence Based Medicine | |
|
Clinical Trials | |
|
Ongoing Trials on Diethylcathinone at Clinical Trials.gov Trial results on Diethylcathinone Clinical Trials on Diethylcathinone at Google
| |
|
Guidelines / Policies / Govt | |
|
US National Guidelines Clearinghouse on Diethylcathinone NICE Guidance on Diethylcathinone
| |
|
Books | |
|
News | |
|
Commentary | |
|
Definitions | |
|
Patient Resources / Community | |
|
Patient resources on Diethylcathinone Discussion groups on Diethylcathinone Patient Handouts on Diethylcathinone Directions to Hospitals Treating Diethylcathinone Risk calculators and risk factors for Diethylcathinone
| |
|
Healthcare Provider Resources | |
|
Causes & Risk Factors for Diethylcathinone | |
|
Continuing Medical Education (CME) | |
|
International | |
|
| |
|
Business | |
|
Experimental / Informatics | |
Overview
Diethylcathinone (also called Diethylpropion and Amfepramone), is a sympathomimetic stimulant drug marketed as an appetite suppressant. It is sold under the brand name Tenuate or Tenuate Dospan, and may also be known as Amfepramone. The popular antidepressant, Wellbutrin (bupropion) is an analogue of this chemical. Both diethylpropion and bupropion have a stimulant effect on the CNS.
Pharmacology
Its mechanism of action is similar to other appetite suppressants such as sibutramine, phentermine and dextroamphetamine. Chemically, it is the N,N-diethyl analog of cathinone and dimethylcathinone. Diethylpropion is manufactured in 25 mg tablets and 75 mg controlled-release tablets (Tenuate®, Tepanil Ten-Tab®). Diethylpropion is classified as a Schedule IV controlled substance in the United States.
It is also used in the treatment of migraine (off-label).
Contraindications
- Hypersensitivity to sympathomimetic amines
- Advanced arteriosclerosis or symptomatic cardiovascular disease
- Moderate or severe hypertension
- Hyperthyroidism
- History of drug abuse
- MAO inhibitor use (within 14 days)
Side effects
- Severe
- Pulmonary hypertension
- Stroke
- Psychosis
- Tachycardia, hypertension, arrhythmia, chest pain
- Ear, nose, and throat
- Xerostomia, metallic taste
- Changes in libido, gynecomastia, menstrual irregularities
- Eye
- Blurred vision
- Nausea/vomiting, constipation, abdominal cramps
- Bone marrow depression, agranulocytosis, leukopenia
- Tremor
- Euphoria, agitation, nervousness, restlessness, dizziness, anxiety, headache, mental depression, seizures
- Rash, hives, alopecia, ecchymosis
- Changes in libido, impotence
See also
References
Antiobesity preparations (A08) | |
|---|---|
| Centrally acting | Phentermine - Fenfluramine - Amfepramone - Dexfenfluramine - Mazindol - Cathine - Clobenzorex - Sibutramine - Rimonabant - Taranabant |
| Peripherally acting | Orlistat |
Table of Contents In Alphabetical Order | By Individual Diseases | Signs and Symptoms | Physical Examination | Lab Tests | Drugs
Editor Tools Become an Editor | Editors Help Menu | Create a Page | Edit a Page | Upload a Picture or File | Printable version | Permanent link | Maintain Pages | What Pages Link HereThere is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies
